Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|June 18, 2011
The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanomaD Oosterhoff, B J R Sluijter, B N Hangalapura, et al.
The Oncologist|December 8, 2000
Biological concepts of prolonged neoadjuvant treatment plus GM-CSF in locally advanced tumorsH M Pinedo, T D de Gruijl, E van Der Wall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerationsS A Luykx-de Bakker, H M Verheul, T D de Gruijl, et al.
Immuno-Oncology Technology|September 2, 2024
An organotypic human melanoma-in-skin model as an in vitro tool for testing Vγ9Vδ2-T cell-based immunotherapyE Michielon, L A King, T Waaijman, et al.
Clinical and Experimental Immunology|June 1, 1994
Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiersT D de Gruijl, J J Moore, E de Vries, et al.
Clinical and Experimental Immunology|April 18, 2020
Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cellsM López González, R van de Ven, H de Haan, et al.
British Journal of Cancer|January 1, 1997
Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesionsH J Bontkes, T D de Gruijl, J M Walboomers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vectorB W Tillman, T D de Gruijl, S A Luykx-de Bakker, et al.
Pageof 4